ETO (MTG8) was ®rst described due to its involvement in the (8;21) translocation frequently observed in acute myeloid leukemias. In the t(8;21) the AML1 gene on chromosome 21 is fused to ETO on chromosome 8. The resultant hybrid protein is comprised of the DNA binding domain of AML-1 and the majority of ETO. This study examines the subnuclear distributions of ETO, AML-1B and AML-1/ETO proteins fused to green¯uorescence protein in living cells using¯uorescence microscopy. Further, we identi®ed a 40 amino acid portion of ETO (amino acids 241 ± 280) that was sucient to cause nuclear import of green¯uorescent protein. Mutational analysis demonstrated that lysine 265 and/or arginine 266 were required for nuclear import of ETO, but that the surrounding basic residues were not critical. ETO interacted with the nuclear import proteins importin-a and b in vitro, and mutations in ETO that abolish nuclear localization also abolished the in vitro interaction with importin-a and b. These data suggest that ETO enters the nucleus via an importin-mediated pathway. Additionally, ETO and AML-1/ETO co-localized to punctate nuclear bodies distinct from those containing promyelocytic leukemia protein. Nuclear body formation was dependent upon a region of ETO N-terminal to the nuclear localization signal. Thus, ETO and AML-1/ ETO reside in potentially novel subnuclear compartments. Oncogene (2000) 19, 3584 ± 3597.
Introduction
The t(8;21) is one of the most common chromosomal translocations associated with acute myeloid leukemia (AML) (Rowley, 1984) . This translocation results in the fusion of the AML1 (CBFA2) gene on chromosome 21 and the ETO (MTG8/CDR) gene on chromosome 8 (Miyoshi et al., 1991; Erickson et al., 1992; Kozu et al., 1993) . The resultant hybrid gene product, AML-1/ ETO, expressed from the AML1 promoter, is thought to be central to leukemogenesis.
A role for AML1 in hematopoiesis is well documented. AML1 encodes several alternatively spliced transcription factors; AML-1 (250 aa), AML-1b (453 aa) and AML-1B (480 aa) (Miyoshi et al., 1991 . AML-1B contains a c-terminal transactivation domain and a 31 amino acid nuclear matrix targeting signal (NMTS) Zeng et al., 1997) . All three proteins bind DNA through the runt homology domain (RHD) (Meyers et al., 1993; Melnikova et al., 1993) . The RHD also mediates heterodimerization with the non-DNA binding partner CBFb (Meyers et al., 1993; Wang et al., 1993) . Together, the AML-1 and CBFb proteins comprise the transcription factor complex core-binding factor (CBF) (Speck and Terryl, 1995; Speck et al., 1999) . The CBF consensus recognition site, TGTGGT, is found in the regulatory regions of genes whose protein products are involved in hematopoiesis Zhang et al., 1996; Uchida et al., 1997; Liberman et al., 1999) . Moreover, mice that are nullizygous for AML1 or CBFb genes die early in gestation and lack de®nitive myeloid and erythroid progenitors in the fetal liver (Okuda et al., 1996; Wang et al., 1996) . Thus, the cumulative data demonstrate a requirement for AML1 activity in normal hematopoiesis.
ETO was ®rst described due to its involvement in the t(8;21) and is known to be a nuclear phosphoprotein (Miyoshi et al., 1991; Erickson et al., 1996) . ETO expression has been documented in the CD 34+ compartment of human bone marrow, suggesting a possible role in hematopoiesis (Erickson et al., 1996) . The ETO-family of proteins now includes three human members (ETO, MTG16 and MTGR1) , two murine members (mETO and ETO-2) and a Drosophila homolog (nervy) (Feinstein et al., 1995; Niwa-Kawakita et al., 1995; Gamou et al., 1998; Calabi and Cilli, 1998; Kitabayashi et al., 1998; Davis et al., 1999) . The recent isolation of ETO-related proteins has expanded our understanding of ETO's modular structure through a clearer de®nition of four conserved domains I, II, III and zinc-®nger (MYND), also called NHR1 ± NHR4, based on amino acid alignments and comparisons of the family members (Feinstein et al., 1995; Kitabayashi et al., 1998; Davis et al., 1999) .
AML-1/ETO retains the DNA binding and heterodimerization functions of the AML-1 proteins but does not contain the transactivation domain or the nuclear matrix targeting signal (NMTS) of AML-1B. Additionally, AML-1/ETO contains the four conserved domains de®ned through comparisons of the ETOfamily proteins. Transient transcription assays demonstrate that AML-1/ETO is a strong repressor of CBFmediated transcription (Frank et al., 1995; Lenny et al., 1995) . Moreover, enforced expression of AML-1/ETO in myeloid progenitor cells prevents granulocyte-colony stimulating factor (G-CSF)-induced dierentiation Kitabayashi et al., 1998 : Ahn et al., 1998 : Kohzaki et al., 1999 . These data led to the hypothesis that AML-1/ETO functions to block blood cell dierentiation through dominant inhibitory eects on CBF. In support of this idea, AML-1/ETO`knock-in' mice die between 11.5 and 13.5 days post-conceptus with a defect similar to the defect in AML1 nullizygous mice (i.e., absence of de®nitive hematopoiesis (Yergeau et al., 1997) ).
Several studies examined the structural requirements for AML-1/ETO to repress CBF-mediated transactivation and to block myeloid progenitor cell dierentiation. A region containing domain II was required for AML-1/ETO to block AML-1B-mediated transactivation of the T-cell receptor b-chain gene enhancer and to prevent G-CSF-directed dierentiation of L-G cells (Kitabayashi et al., 1998) . Further, repression of basal transcription from the multi-drug resistance 1 promoter requires domain II and the zinc-®nger (MYND) (Lutterbach et al., 1998) . Functions assigned to the ETO domains include dimerization (domain II) and interaction with the nuclear co-repressor N-CoR (MYND; zinc ®nger), a protein involved in transcriptional repression via its interaction with a histone deacetylase (Gelmetti et al., 1998; Lutterbach et al., 1998; Wang et al., 1998) . Thus, both domain II and the MYND region likely contribute required activities for AML-1/ETO's role in leukemogenesis.
Clearly, when joined to the runt homology domain, ETO has a powerful eect on transcription and plays a signi®cant role in human disease. This fact underscores the importance of understanding the function and structure of ETO. This study aims to further our understanding of ETO through a structure/function analysis in relation to nuclear import and subnuclear localization. Here we examine the molecular mechanisms by which ETO enters the nucleus and the relationship between the subcellular distributions of AML-1/ETO, ETO and AML-1B. Subcellular distributions were characterized in living cells using an enhanced green¯uorescent protein (GFP)-tag (Tsien, 1998) .
The results shown here identify a 40 amino acid region of ETO that contains a nuclear localization signal (NLS) sucient to direct GFP to the nucleus. This region contains a number of basic amino acids that were tested for their role in ETO nuclear import. Further, we demonstrate an in vitro interaction between ETO and the nuclear import proteins importin-a and b (Gorlich et al., 1994 (Gorlich et al., , 1995 . Finally, we demonstrate that ETO localizes to punctate subnuclear structures. Co-expression studies demonstrate that ETO and AML-1/ETO are found in the same subnuclear structures. These data con®rm previous work suggesting that AML-1/ETO is distributed in a punctate pattern in the nucleus of leukemic cells (Sacchi et al., 1996) and recent data demonstrating that AML-1/ETO and ETO localize to overlapping subnuclear compartments in Saos2 cells (McNeil et al., 1999) . We have extended these results by demonstrating that these subnuclear compartments do not coincide with either promyelocytic leukemia protein (PML) nuclear bodies or SC-35 positive nuclear speckles (Spector et al., 1991; Dyck et al., 1994) .
Results
GFP ± ETO, GFP ± AML-1B and GFP ± AML-1/ETO retain wild-type functions ETO, AML-1B and AML-1/ETO were appended to GFP and their localization studied in living cells bȳ uorescence microscopy. The GFP-tagged cDNAs were transiently expressed in the hematopoietic cell lines K562 and U937 and the human embryonic kidney cell line 293T. GFP-tagged proteins were characterized by Western blot, and a rabbit polyclonal antibody against GFP detected protein bands of the predicted molecular weight ( Figure 1A ). An advantage of using GFP to follow protein localization is the ability to visualize the¯uorescent signal in living cells. However, the addition of the large GFP molecule could interfere with the normal cellular function and, therefore, localization of the tagged proteins. To determine if the GFP-tag interferes with function, the GFP ± AML-1B, GFP ± ETO and GFP ± AML-1/ETO were tested for several known functions of the wild-type proteins. AML-1B and AML-1/ETO bind DNA and dimerize with CBFb through the runt homology domain. We used electrophorectic mobility shift assay (EMSA) to test the DNA binding activity of GFP ± AML-1B and GFP ± AML-1/ETO. EMSA revealed that both GFP ± AML-1B and GFP ± AML-1/ETO bound the AML-1 consensus site, TGTGGT, in a speci®c manner ( Figure  1B ) (Meyers et al., 1993) . Moreover, the DNA-protein complexes were supershifted by addition of the anti-GFP antiserum, but not by pre-immune serum (PI), demonstrating that the DNA binding proteins contain GFP. To test whether GFP ± AML-1B and GFP ± AML-1/ETO could interact with CBFb, we performed a GST-capture assay. 293T cells transiently expressing GFP ± AML-1B or GFP ± AML-1/ETO were metabolically labeled with 35 S-methionine and whole cell lysates prepared from them were mixed with bacterially expressed and puri®ed glutathione-S-transferase (GST) ± CBFb or GST (Shurtle et al., 1995) . GFP ± AML-1B and GFP ± AML-1/ETO bound to GST ± CBFb but not with GST alone ( Figure 1C ; top panel). The expression of the GFP-chimeras in the 293T cells was monitored by immunoprecipitation using the anti-GFP antiserum (+ aGFP) and the arrows indicate the presence of the labeled proteins. The Coomassie blue stained gel is shown below. These data demonstrate that the RHD, required for DNA and CBFb binding, remains functional in the GFP-tagged proteins (Meyers et al., 1993) .
Previously we showed that ETO amino acids 335 ± 392 contained the minimal sequences required for dimerization between ETO family members (Davis et al., 1999) . To test whether GFP ± ETO and GFP ± AML-1/ETO could dimerize through this region, we again used a GST-capture assay. Whole cell lysates were prepared from 293T cells transiently expressing GFP ± ETO and GFP ± AML-1/ETO and metabolically labeled with [ Figure 1 GFP ± ETO, GFP ± AML-1/ETO and GFP ± AML-1B retain wild-type function. (A) Western analysis of GFP ± ETO, GFP ± AML-1/ETO, GFP ± AML-1B or GFP. Whole cell lysates were prepared from 293T cells transiently expressing the proteins as indicated and the proteins were separated on 10% SDS ± PAGE. GFP proteins were detected by using the anti-GFP antisera (1 : 400) and an alkaline phosphatase-conjugated secondary antibody. The mobility and size (kDa) of molecular weight markers are indicated. The asterisk indicates a non-speci®c band seen in all the samples. (B) Electrophoretic mobility shift analysis (EMSA) of whole cell lysates prepared from 293T cells transiently expressing the AML-1B, GFP ± AML-1B and GFP ± AML-1/ETO proteins. Lysates (10 mg) were incubated with radiolabeled double-stranded AML-1 consensus oligonucleotides that contained the AML-1 consensus binding site, TGTGGT, and protein-DNA complexes were separated on a native 4% polyacrylamide gel. The ®rst panel shows wildtype AML-1B and GFP ± AML-1B DNA binding activity as indicated.+Competitor indicates binding reactions with the addition of 100 ng of unlabeled double-stranded oligonucleotide as a speci®c competitor. a-GFP and a-GFP PI indicates addition of 2 ml of anti-GFP antiserum or pre-immune serum, respectively. The asterisk indicates the supershifted DNA/protein complexes. Arrows indicate the position of the expected speci®c protein/DNA complexes. (C) In vitro interaction of GFP ± AML-1B and GFP ± AML-1/ETO with CBFb. The GST capture assay was performed by using whole cell lysate prepared from metabolically labeled 293T cells transiently expressing GFP ± AML-1B or GFP ± AML-1/ETO. Whole cell lysates were incubated with bacterially expressed and glutathione-Sepharose-puri®ed GST or GST ± CBFb proteins, as indicated. The protein-Sepharose complexes were then collected, washed, and resuspended in 2X laemli buer and the proteins were separated on a 10% SDS ± PAGE. Immunoprecipitation of the GFP ± AML-1B and GFP ± AML-1/ETO proteins from the same 293T whole cell lysates were done simultaneously using the a-GFP antiserum and were run on the same gel with the GST-captured proteins. The gel was stained with Coomassie blue, dried and then exposed to X-ray ®lm overnight. The bottom panel shows the stained gel, and the GST protein is indicated above the lanes. a-GFP indicates the lanes containing the immunoprecipitation samples. The asterisk denotes the immunoglobulin heavy chain. The top panel shows the autoradiogram of the GST-capture assay. The two lanes on the right represent immunoprecipitated GFP ± AML-1B and GFP ± AML-1/ETO and the arrows indicate the position of the expected proteins. Exposure time shown is approximately 16 h. (D) GFP ± ETO and GFP ± AML-1/ETO interact with the ETO dimerization domain (ETO domain II, amino acids 335 ± 392) (8). The GST capture assay was performed as described above by using whole cell lysate prepared from metabolically labeled 293T cells transiently expressing GFP ± ETO or GFP ± AML-1/ETO and bacterially expressed and glutathione-Sepharose puri®ed GST and GST ± ETO 335 ± 392. The sepharose-captured proteins and the immunoprecipitated (a-GFP) proteins were separated on 10% SDS ± PAGE. The gel was treated as in C and is shown below and labeled Coomassie blue. The autoradiograph is shown at the top. The arrows indicate the position of the expected immunoprecipitated proteins. (E) Subcellular localization of GFP-tagged AML-1B, ETO and AML-1/ETO in hematopoietic (K562 and U937) and non-hematopoietic (293T) cell lines. GFP alone is shown in the 293T cell line. Fluorescent and Nomarsky (DIC) images are shown for the cell types and proteins as indicated. For clarity of detail, images of GFP ± ETO and GFP ± AML-1/ETO in the U937 cell line are shown magni®ed and are labeled 1 (GFP ± ETO) and 2 (GFP ± AML-1/ ETO). K562 and U937 cells were analysed 20 h following electroporation. 293T cells were transfected using a modi®ed calcium phosphate procedure and analysed 20 h post transfection bacterially expressed and puri®ed GST ± ETO 335 ± 392, containing domain II, or with GST alone (Davis et al., 1999) . As expected, GFP ± ETO and GFP ± AML-1/ETO interacted with GST ± ETO 335 ± 392, but not with GST ( Figure 1D ; top panel). Immunoprecipitations using the anti-GFP antiserum were used to monitor protein expression ( Figure 1D ; top panel,+aGFP). The Coomassie blue stained gel is shown below to demonstrate the presence of the GST or GST-335 ± 392 proteins. This result demonstrates that the GFP-tag does not adversely eect interactions among ETO family members ( Figure 1D ).
Living hematopoietic and non-hematopoietic cells expressing GFP, GFP ± ETO, GFP ± AML-1B, or GFP ± AML-1/ETO proteins were studied by¯uores-cence microscopy. GFP was distributed equally in the nucleus and cytoplasm ( Figure 1E , lowest panel). GFP ± ETO was entirely nuclear ( Figure 1E , upper panel), con®rming previous studies demonstrating a nuclear localization for ETO and the related ETO-2 (Erickson et al., 1996; Davis et al., 1999; McNeil et al., 1999) . ETO has also been detected in the cytoplasm of human Purkinje cells and this dierence may re¯ect dierences in the cell types used in the studies (Sacchi et al., 1998) . GFP ± AML-1B is distributed throughout the nucleus in a diuse/granular pattern ( Figure 1E , upper panel) as shown previously by Adya et al. (1998) . Interestingly, the¯uorescence pattern of GFP ± ETO and GFP ± AML-1/ETO is punctate over a diuse staining in approximately 30% of the cells observed in any given ®eld ( Figure 1E , upper panel). This pattern is more striking for ETO than for AML-1/ ETO and was most easily seen in the hematopoietic cell line U937, but was evident in every cell line analysed. Representative cells for ETO and AML-1/ETO are shown magni®ed for detail ( Figure 1E ; lower right, 1 and 2, respectively). The magni®ed images allow a clearer comparison of the distribution of ETO and AML-1/ETO. Whereas ETO localized in a clearly punctate pattern in the nucleus. AML-1/ETO displayed a more diuse staining, with fewer punctate structures in living cells.
ETO amino acids 241 ± 280 contain an NLS and lysine 265 and/or arginine 266 are required for nuclear entry Although ETO is a nuclear protein, the molecular mechanisms governing its access to the nucleus are unknown. To de®ne the region of ETO required for nuclear localization by functional analysis, we used a series of C-and N-terminal truncations, internal deletions and point mutations of ETO fused to the C-terminus of GFP. The resultant proteins were analysed for their subcellular localization in living hematopoietic and non-hematopoietic cell by¯uores-cence microscopy. A schematic of the proteins used is shown ( Figure 2A ). GFP ± ETO is shown at the top for comparison and the ETO-conserved domains are labeled. Each GFP ± ETO protein presented is designated with a letter (A ± P) and the corresponding microscopy images ( Figure 2C ) are identically labeled for clarity. The results of the analysis are summarized in tabular form for each GFP ± ETO protein analysed. Subcellular localization is presented as nuclear (N), cytoplasmic (C), or both (N/C). The subnuclear distribution is presented as diuse (D), structured (S) or both (D/S) where appropriate. Subnuclear distribution was determined from three independent experiments. Mutant proteins scored as structured produced a nuclear punctate pattern in at least 30% of the cells viewed in four ®elds. Western analysis using the aGFP antiserum con®rmed the expression of the various ETO proteins ( Figure 2B ). Figure 2C shows the Nomarsky and¯uorescence image results for the informative GFP ± ETO proteins analysed. Because the results obtained for each protein were identical between cell types only images for the 293T cell line are shown. Previously, we demonstrated that the zinc®nger region was not required for ETO-2 nuclear import (8). This result was con®rmed with GFP ± ETO 1 ± 513, which lacks the zinc-®nger region but gains nuclear entry ( Figure 2C,a) . Moreover, GFP-ETO 1 ± 402 was nuclear ( Figure 2C,b) , but GFP-ETO 1 ± 248, containing domain I and N-terminal sequences, was impaired for nuclear import ( Figure 2C,c) . In order to address the requirement for amino acids 1 ± 107 in nuclear import we prepared GFP ± ETO proteins beginning at amino acid 108 and ending at 248, 402 and 513, respectively and determined their subcellular localization. GFP ± ETO 108 ± 513 (data not shown) and GFP ± ETO 108 ± 402, which contains domains I and II and the adjoining region were nuclear ( Figure  2C ,e). Like GFP ± ETO 1 ± 248, GFP ± ETO 108 ± 248 was impaired for nuclear import (Figure 2C ,f; compare to panel c). We then tested the subcellular localization of GFP ± ETO 322 ± 402, which contains domain II, and GFP ± ETO 322 ± 513, which contains domains II and III and found that both proteins were cytoplasmic (panel h and data not shown; respectively). The small nuclear accumulation of GFP ± ETO 1 ± 248 may suggest the presence of a weak nuclear localization signal. However, taken together these data clearly demonstrated that residues 108 ± 402 contained a strong nuclear localization signal.
To continue our analysis of the ETO NLS, we appended the region between Domains I and II to GFP. The resultant protein, GFP ± ETO 217 ± 307, and the smaller protein GFP ± ETO 217 ± 280, were nuclear ( Figure 2C ,i and data not shown, respectively). Moreover, GFP ± ETO 241 ± 280 was localized to the nucleus ( Figure 2C,k) . We then prepared GFP ± ETO proteins containing internal deletions of the regions shown to direct GFP to the nucleus and determined their subcellular localization. GFP ± ETOD 217 ± 307 or GFP ± ETO D217 ± 280 were located almost entirely in the cytoplasm (Figure 2Ci , and data not shown; respectively). These data demonstrate that the region de®ned by amino acids 217 ± 280 was both sucient and necessary for nuclear import, and that the region de®ned by amino acids 241 ± 280 was sucient to target GFP to the nucleus. This led us to conclude that the ETO NLS was contained within amino acids 241 ± 280.
Because the classical nuclear localization signals are basic in nature , we examined the 241 ± 280 region for a stretch of basic residues and noted a possible basic NLS (amino acids 241 ± 249: KRRTPDRTK; single letter amino acid nomenclature). However, when this sequence was appended to GFP it was insucient for nuclear targeting. Moreover, deletion of amino acids 241 ± 249 in the full-length ETO protein did not markedly aect nuclear localization (data not shown). These results suggested that the ETO NLS was contained within amino acids 250 ± 280. Comparison of the 250 ± 280 region to the homologous region in ETO family members, including nervy, highlighted the conservation of a pair of basic residues (KR) at position 265 and 266, respectively ( Figure 2D ). Substitution of alanine for both residues completely eliminated nuclear entry in the full-length ETO protein ( Figure 2C,n) . However, alanine substitutions for a conserved arginine at 255 (data not shown) or one at 275 did not aect nuclear import of full-length ETO ( Figure 2C,o) . These data demonstrate a requirement for either K265 or R266, or both, in ETO nuclear import.
Deletion of the NLS in the runt homology domain of AML-1/ETO only minimally perturbs nuclear entry (Tanaka et al., 1998) . This result led us to ask if deletion of the ETO NLS within AML-1/ETO would perturb nuclear entry. GFP ± AML-1/ETO D365 ± 455 lacks the ETO determinants for nuclear entry but was properly imported into the nucleus ( Figure 2C,p) . Thus, AML-1/ETO can use the NLS of the RHD or that of ETO to gain nuclear entry.
Because the ETO NLS appeared to be noncanonical, it was of interest to exam the possible involvement of speci®c transport factors in the nuclear import of ETO. This was examined by testing for protein ± protein interactions between ETO and importin-a and b (Gorlich et al., 1994 (Gorlich et al., , 1995 Gorlich and Mattaj, 1996) . These proteins act as cytoplasmic receptors for basic NLS-containing proteins (Gorlich and Mattaj, 1996; Nigg, 1997) . ETO interacts with GST-importin-a and b, but not GST alone, when tested in a GST capture assay (Figure 3, top panel) . ETO D217 ± 307, which is de®cient for nuclear import, does not interact with GST-importin-a or b (Figure 3, top panel) . The Coomassie blue stained gel is shown below the autoradiogram and demonstrates the presence of the GST proteins (Figure 3, bottom panel) . These results suggest that importin-a and b may facilitate nuclear import of ETO.
ETO is found in punctate subnuclear structures
As mentioned above, the¯uorescence images in Figures  1 and 2 demonstrated that GFP ± ETO¯uorescence is both diuse and punctate in the nucleus of hematopoietic and non-hematopoietic cell lines. We found that the subnuclear localization for the entire panel of truncated and full-length GFP ± ETO proteins was consistent in all the cell lines tested (data not shown). To determine if wild-type ETO (untagged) could be detected in punctate subnuclear structures we probed ®xed 293T cells transiently expressing ETO with antibodies against the ETO zinc ®nger region (aZF). The aZF antibodies were detected by using a Cy-3-conjugated goat anti-rabbit secondary antibody. ETO was detected in a diuse and punctate pattern as seen in Figure 4A ,a (immuno¯uorescence). Non-transfected cells can be seen in the same ®eld, and serve as an internal control. Con®rmation of the expression of ETO in these cells is shown by Western analysis below the immuno¯uorescence data (aZF; ETO). These data con®rm recently published results demonstrating that ETO localizes to discrete subnuclear compartments when expressed in Saos2 cells (McNeil et al., 1999) . Next, the molecular determinants governing the entry of ETO into subnuclear bodies was examined by using deleted forms of ETO. The nuclear distribution of the GFP ± ETO proteins shown in Figure 2 suggested that both ETO domains I and II (GFP ± ETO 108 ± 402) could be involved in nuclear body formation. This hypothesis is consistent with the distribution of GFP ± ETO D114 ± 216, which lacks domain I. In contrast to wild-type ETO, ETO D114 ± 216 was diusely located in the nucleus (compare Figure 4A,b and c) . Again, con®rmation of the expression of ETO and GFP ± ETO D114 ± 216 in these cells is shown by Western analysis below the microscope images (aGFP; GFP ± ETO and GFP ± ETO D114 ± 216). From this result we conclude that determinants within amino acids 114 ± 216 are required for ETO nuclear body formation. However, from data presented in Figure 2C , 1 ± 248 it is clear that amino acids 114 ± 216 are not sucient for ENB formation. We propose to term these punctate structures ETO nuclear bodies (ENB).
ENB were tested for co-localization with two known nuclear bodies, nuclear speckles that contain the essential non-snRNP splicing protein SC-35 and PML bodies (Lamond and Earnshaw, 1998) . PML bodies, also called PML oncogenic domains (PODs). vary in number between 10 and 30 per nucleus and are thought to be nuclear matrix-associated (Hodges et al., 1998) . Nuclear speckles are enriched in splicing factors (Spector et al., 1991) . Co-localization studies were done by transiently transfecting cells with GFP ± ETO, ®xing the transfected cells and subjecting them to indirect immuno¯uorescence using monoclonal antibodies against either PML or SC-35. The GFP ± ETO, GFP ± ETO 1 ± 513 and GFP ± AML-1/ETO were easily detected in punctate nuclear structures (Figure 4B ,C; GFP). As expected, the PML bodies and the SC-35 positive speckles were seen as punctate structures in the cell nucleus (Figure 4B ,C; red/Cy-3). When separate images were merged it was clear that GFP ± ETO, GFP ± ETO 1 ± 513 and GFP ± AML-1/ETO did not co-localize with PML bodies or with the SC-35 positive nuclear speckles (Figure 4B ,C; respectively). Enforced expression of ETO did not alter the distribution of either the SC-35 positive speckles or the PML bodies in the cell lines analysed (data not shown).
The nuclear distribution of ETO and AML-1/ETO were compared by co-expression of the two proteins. A yellow variant GFP ± ETO (YFP ± ETO) and a cyan variant GFP ± AML-1/ETO (CFP ± AML-1/ETO) were transiently expressed in 293T cells. Fluorescence images of the GFP color variants were captured separately using the appropriate ®lter sets (Figure 5, yellow or cyan) . Speci®city of the ®lters is shown at the top of Figure 5 . Note that YFP ± ETO is only visualized by using the yellow ®lter, but not the cyan ®lter. Conversely, CFP ± AML-1/ETO is only visualized by using the cyan ®lter. For ease of visualization the YFP and CFP variants were psuedocolored green and red. respectively. When YFP ± ETO and CFP ± AML-1/ETO were co-expressed and their color separated images merged, the merged image demonstrated exact co-localization as shown by the yellow color ( Figure 5B, merge) . In the control experiment, YFP did not co-localize with CFP ± AML-1/ETO and CFP did not co-localize with YFP ± ETO. These studies demonstrate that ETO and AML-1/ETO can co-localize in ENB ( Figure 5 ). This experiment was repeated by co-expressing a dimerization-de®cient ETO with AML-1/ETO and again the proteins co-localized. However, we did notice an increase in the amount of diuse AML-1/ETO in the cells expressing the dimerization-de®cient ETO in comparison to those cells expressing ETO (data not shown). This suggests that AML-1/ ETO can localize to ENB independent of dimerization with ETO, but that dimerization with ETO may be one of the determinants for AML-1/ETO subnuclear localization.
Discussion
Transport of proteins across the nuclear pore complex is generally signal-dependent (Gorlich and Mattaj, 1996; Nigg, 1997) . One (monoparite) or two (bipartite) clusters of basic amino acids characterize classical nuclear localization sequences (NLS) (Makkerh et al., 1996; Gorlich and Mattaj, 1996) . In the classical bipartite NLS, a mutation-tolerant spacer separates the two essential clusters of basic amino acids Robbins et al., 1991) . Cytoplasmic receptors for basic NLS containing proteins have recently been identi®ed and are known collectively as importins (Adam, 1995) . Importin-b directs nuclear localization of basic nuclear localization signal (NLS) containing proteins through the adapter protein importin-a (Gorlich et al., 1994 (Gorlich et al., , 1995 Gorlich and Mattaj, 1996) .
Although ETO was known to be a nuclear protein, prior to this study the molecular mechanisms governing its access to the nucleus had not been investigated, and candidate NLS sequences in ETO had not been proposed. In this study, a small region in ETO containing a strong NLS is de®ned. We found that ETO amino acids 241 ± 280 are sucient to direct nuclear import of GFP. This region is highly conserved among ETO family members and contains the relatively basic sequence KRRTPDRTK (amino acids 241 ± 249; single letter amino acid nomenclature). However, this sequence is not sucient to target GFP to the nucleus and its deletion from ETO only minimally eects nuclear entry (Y Odaka, unpublished data). In contrast, simultaneous substitution of alanine for lysine 265 and arginine 266 in the full-length ETO protein completely abolishes nuclear import. This analysis demonstrates that ETO amino acids 241 ± 280 are sucient to target a heterologous protein to the nucleus but the basic residues at 241 ± 249 are dispensable, suggesting that the ETO NLS is within Figure 2 De®nition of the ETO NLS. (A) Schematic representation of the structure of GFP ± ETO and the GFP ± ETO derivatives analysed for their subcellular localization by¯uorescence microscopy. Full-length GFP ± ETO is shown at the top for comparison. In all cases, GFP is fused to the N-terminus of the ETO proteins. The domains that are conserved among ETO family members are indicated (shaded boxes) and are labeled DI-III and ZF (corresponds to NHR1 ± 4). Each protein is named to indicate the Nterminal and C-terminal amino acid of the segment of ETO (MTG8b) appended to GFP. GFP ± AML-1/ETO D365 ± 455 is abbreviated as GFP-A/E D365 ± 455. The runt homology domain is indicated as a crosshatched box and is labeled RHD. The asterisk indicates the approximate location of the basic to alanine substitutions. Each protein is assigned a letter (A ± P) so that the corresponding microscopy data can be easily followed. The subcellular localization is given as nuclear (N), cytoplasmic (C) or both (N/C) for each protein analysed. The subnuclear distribution is given as diuse (D), structured (S) or both in the same nuclei (D/S). (B) Western analysis of whole cell lysates prepared from 293T cells transiently expressing the GFP ± ETO or GFP ± AML-1/ETO D365 ± 455 proteins as labeled above the lanes and detected with the anti-GFP antiserum. The expected molecular weight protein was identi®ed in each case. The size and mobility of the molecular weight markers are indicated. (C) The subcellular location of the GFP ± ETO and GFP ± AML-1 ETO proteins was determined in 293T cells by using¯uorescence microscopy. Both DIC and uorescence images are shown for informative GFP ± ETO mutations only. The¯uorescence images are labeled with letters and correspond to the labels in (A) (a, GFP ± ETO 1 ± 513; b, GFP ± ETO 1 ± 402; c, GFP ± ETO 1 ± 248; e, GFP ± ETO 108 ± 402; f, GFP ± ETO 108 ± 248; h, GFP ± ETO 322 ± 402; i, GFP ± ETO 217 ± 307; k, GFP ± ETO 241 ± 280; l, GFP ± ETO D217 ± 307; n, GFP ± ETO 265K-A, 266R-A; o, GFP ± ETO 275 R ± A; P, GFP ± AML-1/ETO D 365 ± 455.) (D) A comparison of the ETO amino acid sequence from 241 ± 280 to the homologous region in the ETO family members. Sequences shown are human ETO, MTG16, MTGR1, murine ETO (mETO), ETO-2 (murine) and Drosophila Nervy. The asterisk indicate amino acids targeted by alanine substitutions. The alignment shown is a modi®cation of one previously presented (24, 17) . Amino acids conserved to identity in all family members are bolded amino acids 250 ± 280. Because lysine 265 and/or arginine 266 are absolutely required for ETO nuclear import we asked if the ETO NLS was a modi®ed bipartite signal. To do this, we substituted alanine for the remaining basic residues contained within amino acids 250 ± 280. Arginine 255 is spaced 10 residues Nterminal to the critical basic residues at 265/266, and is in an appropriate position for a bipartite NLS. However, alanine substitution for arginine 255, or arginine 275 does not interfere with nuclear import of full-length ETO. This analysis indicates that the ETO NLS does not conform to a classical polybasic NLS such as that exempli®ed by SV40 T antigen (PKKKRKV) or to a modi®ed bipartite structure . Instead it may be more like the recently described Ran binding protein 3 (RanBP3) NLS (Welch et al., 1999) . Like the ETO NLS, the RanBP3 NLS (SDREDGNYCPPVKRERTS) contains a lysine/arginine pair required for nuclear import (shown in bold) but does not appear to be a modi®ed bipartite NLS, because the N-terminal arginine residue is not required for nuclear import (underlined). Welch et al. (1999) suggests that the RanBP3 NLS is most similar to that of c-Myc (PAAKRVKLD; Dang and Lee, 1988) . Thus, the ETO NLS shares features with the unusual NLS of both RanBP3 and c-Myc. In addition to examining the requirement for basic residues in ETO nuclear import, we tested the requirement for a potential PKC phosphorylation site at serine 264 and saw no eect on nuclear import when alanine was substituted at this site (Y Odaka, unpublished data).
Because the ETO NLS requires basic residues but appears to be non-classical in character, it was of interest to determine if ETO would interact with the nuclear import proteins. ETO, but not the predominantly cytoplasmic protein ETO D217 ± 307 interacts with both importin-a and importin-b. Clearly, we have not excluded the possibility that ETO gains nuclear import via a piggyback mechanism (i.e., in concert with a classical NLS-containing protein). However, the data presented here suggests that ETO enters the nucleus via an importin-mediated pathway by using a non-classical NLS similar to that of RanBP3. The unusual nature of the ETO NLS may suggest that one of the other importin-a isoforms might preferentially recognize ETO (Weis et al., 1995; O'Neil and Palese, 1995; Moroianu et al., 1995; Takeda et al., 1997; Nachury et al., 1998; KoÈ hler et al., 1997) . Previous studies have found dierential binding of nuclear proteins to the various isoforms of importin-a. For example, the NLS of RanBP3 preferentially interacts with importin-a-3 (Welch et al., 1999) .
Chromosome translocations in leukemias most often result in the juxtaposition of two genes encoding a protein with altered function from that of its parental proteins. Comparison of the subcellular localization of the wild-type components to their derivative chimeric proteins has in some cases suggested mechanisms whereby the fusion proteins act in leukemia. An example of this is the t(15;17), which generates a fusion between the promyelocyte (PML) and retinoic acid receptor a proteins (de TheÂ et al., 1991) . PML is found in macromolecular structures (PML bodies) and the chimeric PML ± RARa disrupts these structures. Retinoic acid treatment induces dierentiation of the leukemic cells and reorganization of the PML bodies raising the possibility that inappropriate nuclear localization of one or more of the factors associated with PML bodies may play a role in transformation (Hodges et al., 1998) . Therefore, it is of interest to Figure 3 ETO interacts with importin-a and -b in vitro. GST, GST-importin-a or GST-importin b were produced in E. coli and puri®ed on GST-Sepharose. The sepharose-linked proteins were incubated with in vitro-produced and 35 S-methionine-labeled ETO and ETO D217 ± 307 protein for 1 h. Pelleted and washed beads were resuspended in gel loading buer and separated on 10% SDS ± PAGE. Coomassie stained gels were dried and subjected to autoradiography. The autoradiograph is shown on top. Two ml of the programmed rabbit reticulocyte lysate is shown for comparison (ETO invT/T and ETO D217 ± 307 invT/T). Arrows indicate the position of the full-length invT/T proteins. The Coomassie blue stained gel is shown below. The asterisk denotes BSA (see Materials and methods). The arrowheads indicate the position of the full-length GST or GST-recombinant proteins. The exposure time shown is 20 h. The size and mobility of the molecular weight markers are indicated Nuclear import and subnuclear localization of ETO Y Odaka et al Figure 4 GFP ± ETO and ETO localize to punctate nuclear bodies (ENB) and domain I is required for this localization (A,a).
Immuno¯uorescence of 293T cells transiently expressing ETO. The 293T cell line was transfected with a vector expressing wild-type ETO. After 20 h the cells were ®xed (3.5% paraformaldehyde) and probed with a rabbit polyclonal against the zinc ®nger region of ETO (aZF). A Cy3-conjugated goat anti-rabbit antibody was used to detect the primary antibody. DAPI staining delineates the nucleus and is labeled. The speci®city of the antiserum is demonstrated by Western analysis of whole cell lysates from 293T cells transfected with the ETO cDNA or vector alone and probed with the aZF antiserum. (B and C) Sequences within A.A.114 ± 216 are required for formation of ETO nuclear bodies. 293T cells were made to transiently express GFP ± ETO D114 ± 216 or GFP ± ETO and the images were detected by¯uorescence microscopy as labeled. The¯uorescence and Nomarsky images for GFP ± ETOD114 ± 216 or GFP ± ETO are magni®ed twofold from the original captured images for visualization of the ETO nuclear bodies. Western analysis using aGFP antisera detected the appropriate proteins in whole cell lysates prepared from the cells analysed above. (B) K562 cells transiently expressing GFP ± ETO, GFP ± ETO 1 ± 513 (lacking the ETO zinc-®nger region), or GFP ± AML-1/ETO were ®xed and stained with a monoclonal antibody against PML and detected using a Cy3-conjugated goat anti-mouse secondary antibody (red). For the same cell, GFP images (green) and PML images (red) are shown alone or merged as indicated. (C) K562 cells transiently expressing GFP ± ETO, GFP ± ETO 1 ± 513 or GFP ± AML-1/ETO were ®xed and stained with a monoclonal antibody against SC-35 and detected using a Cy3-conjugated goat anti-mouse secondary antibody (red) determine the intracellular localization for each protein involved in a translocation, and for the translocation protein itself. AML-1/ETO is a leukemia-associated chimeric transcription factor in which the DNA binding domain of AML-1 is fused to ETO. Thus, in AML-1/ETO the transactivation domain and the nuclear matrix targeting signal of AML-1B are replaced by ETO-speci®c functions. The replacement of the AML-1B nuclear matrix targeting signal with ETO suggests that AML-1/ETO might display an altered subnuclear localization. To address this issue, we compared the subcellular distribution of AML-1/ETO and its constituent proteins AML-1B and ETO in living cells. ETO is distributed in both a diuse and punctate pattern in the nucleus in comparison to AML-1B, which is diusely granular (Adya et al., 1998) . We have named these punctate nuclear bodies ETO nuclear bodies (ENB). Mutational analysis demonstrates that domain I is required, but not sucient, for subnuclear structure formation. Because ETO D114 ± 216, lacking domain I but retaining dimerization functions, is diusely distributed in the nucleus, it appears unlikely that the ENB contain only multiple copies of ETO. Removal of the zinc-®nger (MYND) region alters the localization of GFP-ETO such that the diuse staining is no longer visible. This result suggests a possible regulatory role for protein interactions mediated by the zinc ®nger in ENB formation.
In living cells, AML-1/ETO displays a localization pattern that is somewhat more diusely distributed in the cell nuclei with fewer, less distinct punctate bodies when compared to ETO. However, when cells expressing GFP ± AML-1/ETO, or GFP ± ETO, are ®xed and then examined by¯uorescence microscopy the punctate structures become very distinct. This suggests that the ®xing procedure causes some of the diusely located protein to be lost, causing the nuclear bodies to be more easily visualized (see Figure 4B and C). When ETO and AML-1/ETO are co-expressed. AML-1/ETO becomes distinctly punctate and the two proteins exactly co-localize. Our data is in agreement with recently published work demonstrating that ETO and AML-1/ETO co-localize in distinct subnuclear compartments in ®xed Saos2 cells (McNeil et al., 1999) . Further, our data extends these observations by demonstrating that the ENB do not co-localize with PML-nuclear bodies. Also, ENB do not co-localize with nuclear speckles identi®ed with a monoclonal antibody against the non-snRNP protein SC-35. We have not yet determined if ENB co-incide with other nuclear bodies such as coiled bodies or gems (Lamond Figure 5 YFP ± ETO and CFP ± AML-1/ETO co-localize to subnuclear domains. The 293T cells were transiently transfected with vectors expressing the cDNAs as indicated (CFP ± AML-1/ETO is abbreviated as CFP-A/E). The transiently transfected cells containing either YFP ± ETO+CFP, CFP ± AML-1/ETO+YFP or YFP ± ETO+CFP ± AML-1/ETO were examined under uorescence microscopy and the images captured using ®lters speci®c for YFP (labeled yellow) or CFP (labeled cyan). Separate images were then merged and co-localization is visualized as yellow. The separate images for FP ± AML-1/ETO and YFP ± ETO, and the merged images are mangni®ed and shown again on the right to highlight the detail and Earnshaw, 1998). However, it is intriguing to suggest the possibility that ETO can enter previously unidenti®ed nuclear bodies of unknown function and that protein ± protein interactions or protein modi®ca-tions dictate entry into and exit from these nuclear bodies.
AML-1/ETO is hypothesized to function as a dominant inhibitor of CBF-mediated transcription. AML-1/ETO retains each of the regions conserved among ETO family members, namely DI, DII, DIII and ZF (MYND) (Feinstein et al., 1995; Kitabayashi et al., 1998; Davis et al., 1999) . Cumulative data suggests that dominant interference of CBF activity requires at least domain II Kitabayashi et al., 1998) and the zinc-®nger region (Gelmetti et al., 1998; Wang et al., 1998; Lutterbach et al., 1998) . However, the zinc-®nger region was shown to be dispensable for AML-1/ETO to block G-CSFinduced dierentiation of L-G cells (Kitabayashi et al., 1998) . Domain I has homology to the transcription accessory factor TAF 110 but its function in ETO is unknown (Feinstein et al., 1995) . This study demonstrates that Domain I functions in the control of the subnuclear tracking of ETO. Further, we demonstrate that ETO sequences supply a subnuclear targeting function to AML-1/ETO. It will be interesting to determine what role, if any, ETO nuclear bodies play in t(8;21) leukemia.
Materials and methods

Plasmid preparation
The enhanced GFP cDNA (Clontech Laboratories, Inc., Palo Alto, CA, USA) was ampli®ed by PCR using the following DNA oligomers as primers: 5'-TAGGTACCTCGCCAC-CATGGTGAGCAAGGGCGA-3' and 5'-TACTCGAGTC-TAGACTTGTAGAGCTCGTCCAT-3'. The 3' oligomer contains a XbaI and XhoI site for cloning purposes. The ampli®ed cDNA was subcloned into pCDNA3 and into pBluescriptSK. The AML-1B, ETO and AML-1/ETO cDNAs were ligated to the C-terminus of the enhanced GFP cDNA at the XbaI or XhoI site; the junction was designed to conserve the protein open reading frame. The DNA fragments were subcloned, their DNA sequence determined, and then cloned into the appropriate wild-type cDNAs using internal restriction sites. A similar procedure was followed for subregions of ETO. The following subregions of ETO were ampli®ed by PCR using the DNA oligonucleotide primers indicated: ETO 1 ± 248, ETO 1 ± 402, and ETO 1 ± 513; 5' primer: 5'-TATCTAGAATGATATCT-GTCAAAAGAAAC-3'. ETO 1 ± 248 3' primer: 5'-TAGGAT-CCTCAGGTTCTGTCTGGAGTTCG-3'. ETO 1 ± 402. 3' primer: 5'-TATCTAGATCATAAGTCCTCGGCGTCACT-3. ETO 1 ± 513, 3' primer: 5'-TATCTAGATCACTCGCTT-GAATCCTCCTG-3'. ETO 108 ± 248. 5' primer: 5'-TATCTA-GATCTCTGGCTAATCAACAG and 3' primer 5'-TAGGA-TCCTCAGGTTCTGTCTGGAGTTCG-3'. ETO 108 ± 402 and ETO 108 ± 513 were ampli®ed with the appropriate combinations of the above primers (i.e. 108 5' primer and 402 or 513 3' primer). Fragments including ETO 322-402 and ETO 322-513 were ampli®ed with the 5' primer 5'-TCT-AGAGACCTCAGGGACAGAAAC-3'.
Fragments including ETO 217 ± 280 and ETO 217 ± 307 were ampli®ed with the 5' primer 5'-TATCTAGACTGCTT-CTGGATGCCAGCACC-3' and the 3' primers 5'-TATCTA-GAGAAAATGGCTTTGACAG-3' or 5'-TAGGGCCCCTA-AATGGCCATATCATCCAA-3', respectively. A fragment including ETO 241 ± 280 was ampli®ed with the 5' DNA primer 5'-TATCTAGAAAGAGGCGAACTCCAGAC-3' and the 3' 280 primer. ETO D217 ± 307 was prepared by using the 5' primer 5'-TACCTCGCCCAGCATGAACAGGCCC-ACCACTACAGGGACTCC-3' and the 3' primer 5'-GGAG-TCCCTGTAGTGGTGGGCCTGTTCATGCTGGGCGAG-GTA-3' using the Quick Change Site-Directed Mutagenesis Kit (Stratagene). ETO D217 ± 280 was ampli®ed with the 5' primer 5'-GCC-CAGCATGAACAGGGCTTATCCTACCAGCC-3' and the 3' primer 5'-CTGGTAGGATAAGCCCTGTTCATGCTGG-GCGAG-3'. ETO D114 ± 216 was prepared by digesting the ETO cDNA with PvuII and religating it to produce an ETO cDNA that lacks the internal PvuII fragment. GFP ± ETO 265K ± A/266R ± A was prepared by using PCR and the DNA oligomers TCAGAACATCCAAGCGCGGCACCAT-GCACTATTAGC and GCTAATAGTGCATGGTGCCGC-GCTTGGATGTTCTGA. GFP ± ETO 275R ± A was prepared by using PCR and the DNA oligomers CCAGGCC-AGGCGTACAGTCC and GGACTGTACGCCTGGCCT-GG. Removing the GFP cDNA and replacing it with the appropriate color variant made the yellow variant GFP ± ETO and the cyan variant GFP ± AML-1/ETO. Large-scale DNA preparations used an alkaline lysis procedure followed by polyethylene glycol puri®cation. DNA oligomers were from Oligos Etc. or Integrated DNA Technologies. DNA sequencing was performed at the Iowa State University Sequencing Facility.
Cell culture and transfection
The cell lines 293 and 293T were maintained in Dulbecco's modi®ed Eagle's medium (DMEM) containing 10% fetal calf serum, 1% pen-strep and L-glutamine. K562 and U937 cells were maintained in RPMI containing 15% fetal calf serum, 1% pen-strep and L-glutamine. The 293 and 293T cells were plated on slides and transfected using a modi®ed calcium phosphate procedure (Chen and Okayama, 1987) . The cells were washed after 10 h and incubated in fresh DMEM for 12 h prior to analysis. K562 and U937 cells (5610 6 ) were electroporated using a Gene Pulser (Bio-Rad Laboratories) set at 960 mfd and 240 volts at room temperature in RPMI+10% FCS (200 ml). K562 and U937 cells were analysed 20 ± 24 h following electroporation.
Electrophoretic mobility shift assays (EMSA)
Cell extracts were prepared by washing cells with Trisbuered saline prior to sonication on ice in microextraction buer (20 mM HEPES pH 7.4. 450 mM NaCl, 0.2 mM EDTA) 0.5 mM dithiothreitol, 25% glycerol). The lysates were clari®ed by high-speed centrifugation, and equal amounts of protein were used in EMSA. Protein/DNA binding reactions were carried out at room temperature (30 min) in buer containing 20 mM HEPES, pH 7.8, 1 mM MgCl 2 , 0.1 mM EGTA, 0.4 mM dithiothreitol, 40 mM KCl and 150 mg poly d[I-C]. The AML-1 binding site was prepared by annealing complementary DNA oligomers as previously described (Meyers et al., 1993) . Annealed oligomers were labeled with 32 P-dATP in a standard Klenow reaction. Labeled oligomers (100 ng) were extracted once with phenol, precipitated twice with 2 M NH 4 OAc, dried, and resuspended in sterile water.
Western analysis
The aGFP antiserum was prepared in rabbits immunized with puri®ed full-length GFP protein. The aZF antiserum was prepared in rabbits immunized with ETO residues 393 ± 604, containing the zinc-®nger region (Animal Resource Center, LSU Health Science Center, USA). Expression of the GFP-tagged proteins and their derivatives was monitored by Western analysis. Cells transiently transfected with the pCDNA3 ± GFP ± ETO, AML-1, ETO, AML-1B, their derivatives or vector alone were harvested, whole cell extracts prepared and separated on 10% SDS ± PAGE. The proteins were transferred to a nitrocellulose membrane and detected using the rabbit polyclonal antibody against full-length GFP (1 : 400 in 1% nonfat milk) or ETO zinc-®nger (1 : 400 in 1% nonfat milk) and a goat anti-rabbit IgG (H+L)-alkaline phosphatase conjugated secondary antibody (Bio-Rad Laboratories). Antibody complexes on the membrane were detected using the Immun-Star detection kit (Bio-Rad laboratories) or Sigma fast tablets (Sigma Chemical Company). Chemiluminescence was detected by exposing the membrane to Kodak X-ray ®lm for 20 s to 2 min.
In vitro GST-capture assays
The in vitro interactions of GFP ± AML-1B and GFP ± AML-1/ETO with CBFb, and that of GFP ± ETO and GFP ± AML-1/ETO with GST ± ETO domain II (335 ± 392) were analysed by using glutathione-S-tranferase (GST)-capture assays approximately as described previously . 293T cells were transiently transfected with the appropriate expression vectors and 24 h following transfection, cells were labeled with 200 mCi/mL 35 S-methionine (ICN Pharmaceuticals, Inc.) for 1.5 h. The cells were harvested and lysates were prepared in immunoprecipitation (IP) buer [50 mM Tris-HCl (pH 7.5) 150 mM NaCl, 0.4% NP-40, 1 mM EDTA) by sonication on ice. An aliquot of the cell lysate was mixed with bacterially produced and glutathione-Sepharose-puri®ed GST, GST ± CBFb, or GST ± ETO 335 ± 392, as appropriate, for 1 h at 48C. Protein complexes were incubated with GST ± Sepharose, pelleted and washed four times in IP buffer+0.1% BSA, once in IP buer without BSA and resuspended in 30 ml of 2X gel loading buer. Samples were analysed on 10% SDS ± PAGE. Expression of the proteins in 293T cells was monitored by immunoprecipitation using the a-GFP antiserum (15 ml). Gels were stained with Coomassie blue to detect the GST proteins, destained, dried and exposed to Kodak XAR ®lm overnight at room temperature.
The interaction between ETO and importin-a and b (Moore et al., 1999) was also analysed by using a GSTcapture assay. However, the ETO and ETO D217 ± 307 proteins were prepared in rabbit reticulocytes programmed with the appropriate cDNA and [ 35 S]-methionine (Dupont NEN). GST-importin-a and b were produced in E. coli, puri®ed on glutathione-Sepharose beads and incubated with 15 ml of the programmed rabbit reticulocyte lysate. Samples were then processed as indicated above.
Immunofluorescence, microscopy and image analysis Indirect immuno¯uorescence Indirect immuno¯uorescence was performed either with K562 or 293T cells that were ®xed in 3.5% paraformaldehyde for 30 min at room temperature. The cells were then blocked in 10% normal goat serum (Sigma) before being probed with the SC-35 monoclonal antibody (Santa Cruz), the PML monoclonal antibody (Santa Cruz) or the aZF rabbit polyclonal antiserum. The SC-35 and PML antisera were diluted 1 : 2000 and 1 : 500, respectively, in 1X PBS+0.2% Triton X-100 prior to use. Both the SC-35 and PML antisera were detected by using a Cy-3 conjugated goat anti-mouse secondary antibody (Sigma) diluted 1 : 1000 in 1X PBS Triton X-100. The red (Cy-3) and GFP¯uorescence signals were visualized using an Olympus BX-60 epi¯uorescence microscope equipped with appropriate single-and dual-pass ®lters speci®c for FITC and Cy-3¯uorescence and digital image processing (Chroma Technology Corp.). Monochrome images were captured at the microscope using a cooled-CCD camera and pseudocolored composite images were produced using software speci®cally designed for multi-color image analysis.
Direct fluorescence microscopy
Cells grown on slides were transfected with cDNAs for GFP, GFP ± AML-1B, GFP ± AML-1/ETO, and GFP ± ETO, and their derivatives. The GFP-¯uorescence signals were visualized by using an Olympus AX-70 epi¯uorescence microscope equipped with the appropriate ®lter (41001; Chroma Technology Corp.). Monochrome images were captured at the microscope using a cooled-CCD camera (Nu 200: Princeton Instruments) and pseudocolored images were produced using software speci®cally designed for multicolored image analysis (IP-Lab; Scanalytics, Inc.). Images of the yellow and cyan GFP-variants were visualized and captured at the microscope by using the JP4 dual band ®lter set (Chroma Technology Corp.). Pseudocolored composite images were produced using IP-Lab software.
